Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Qu for assay and technical support
Potential Benefits Targets three metabolic pathways simultaneously (GLP-1, GIP, glucagon), addressing both appetite and energy expenditure in a way single and dual-agonist agents cannot Strong appetite control and satiety support through combined GLP-1 and GIP receptor activation, including central hypothalamic satiety signaling Hepatic fat oxidation and increased resting energy expenditure through glucagon receptor activation: the layer that distinguishes retatrutide from semaglutide and tirzepatide Studied for significant weight reduction in phase 2 clinical trials: the highest-dose group in the NEJM 2023 trial lost an average of approximately 24% of body weight at 48 weeks (controlled-trial average
Opslag en hantering Bewaar gelyofiliseerd poeder bij -20C in originele verzegelde vial Bescherm tegen direct licht Na reconstitutie: bewaar bij 28C en gebruik binnen 14 dagen Vermijd herhaalde freeze-thaw-cycli van de gereconstitueerde oplossing Veelgestelde vragen Melanotan 1 in het kort
Do not disregard professional medical guidance or delay seeking clinical oversight based on information read on this platform
US$ 29.96
US$ 21.20
US$ 24.27
US$ 20.32
US$ 25.63
